Why the study?
Does insulin treatment resolve diabetic lipemia in patients with severe symptomatic diabetes?
Does insulin treatment resolve diabetic lipemia in patients with severe symptomatic diabetes?
Diabetic lipemia is a specific clinical syndrome in severe symptomatic diabetes that resolves with insulin therapy.
Answers are grounded in this paper and cite their sources.
May support insulin for diabetic lipemia; leaves open prospective validation in modern cohorts.
DIABETIC lipemia (milky plasma), first described in the nineteenth century, remains a well recognized but rare manifestation of uncontrolled diabetes mellitus. Although prompt diagnosis and insulin treatment have probably reduced the incidence of hyperlipemia in symptomatic diabetes, reports of this poorly understood syndrome continue to appear.1 2 3>Since lipemia may be associated with varying degrees of carbohydrate intolerance in a wide spectrum of patients, the term "diabetic lipemia" will be restricted to describe the lipemia associated with severe symptomatic diabetes. This lipemia characteristically is abolished by insulin treatment. The patient with this clinical syndrome should be readily distinguished from the . . .
No takes yet. Share an insight, caveat, or question.
Bagdade et al. (1967) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: